| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Chief Accounting Officer | Common Stock | 6,500 | $54,925 | $8.45 | 02 Jan 2026 | Direct |
| Cartesian Therapeutics, Inc. | Chief Accounting Officer | Employee Stock Option (right to buy) | 19,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2026 | 2 | $0 | 4 | Chief Accounting Officer | 06 Jan 2026, 16:18 |
| RNAC | Cartesian Therapeutics, Inc. | 27 Oct 2025 | 1 | $0 | 4 | Chief Accounting Officer | 28 Oct 2025, 16:05 |
| RNAC | Cartesian Therapeutics, Inc. | 27 Oct 2025 | 0 | $0 | 3 | Chief Accounting Officer | 28 Oct 2025, 16:03 |